PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24585360-7	2014	By coating the poly(butyl cyanoacrylate) nanoparticles with, e.g., ApoE, it is also possible to circumvent the BBB via the LDL-receptor.	Enbucrilate	15-40	apolipoprotein E	Homo sapiens	67-71	
20230014-0	2010	ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model.	Enbucrilate	15-40	apolipoprotein E	Homo sapiens	0-5	
20230014-4	2010	In the present study, we have formulated apolipoprotein E3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin (ApoE3-C-PBCA) to provide photostability and enhanced cell uptake of curcumin by targeting.	Enbucrilate	68-93	apolipoprotein E	Homo sapiens	41-58	
20230014-4	2010	In the present study, we have formulated apolipoprotein E3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin (ApoE3-C-PBCA) to provide photostability and enhanced cell uptake of curcumin by targeting.	Enbucrilate	68-93	apolipoprotein E	Homo sapiens	129-134	
22890189-3	2012	Anionic polymerization method was employed for the preparation of apolipoprotein-E3 mediated curcumin loaded poly(butyl)cyanoacrylate nanoparticles (ApoE3-C-PBCA) and characterized for size, zeta potential, entrapment efficiency, photostability, morphology, and in vitro release study.	Enbucrilate	109-133	apolipoprotein E	Homo sapiens	66-83	
22890189-3	2012	Anionic polymerization method was employed for the preparation of apolipoprotein-E3 mediated curcumin loaded poly(butyl)cyanoacrylate nanoparticles (ApoE3-C-PBCA) and characterized for size, zeta potential, entrapment efficiency, photostability, morphology, and in vitro release study.	Enbucrilate	109-133	apolipoprotein E	Homo sapiens	149-154	
16036306-2	2005	Polysorbate 80-coated polybutylcyanoacrylate (PBCA) nanoparticles, preferentially adsorbing apolipoprotein E (apoE) on their surface, have previously been considered to deliver various drugs to the brain.	Enbucrilate	22-44	apolipoprotein E	Homo sapiens	92-108	
16036306-2	2005	Polysorbate 80-coated polybutylcyanoacrylate (PBCA) nanoparticles, preferentially adsorbing apolipoprotein E (apoE) on their surface, have previously been considered to deliver various drugs to the brain.	Enbucrilate	22-44	apolipoprotein E	Homo sapiens	110-114	
16036306-2	2005	Polysorbate 80-coated polybutylcyanoacrylate (PBCA) nanoparticles, preferentially adsorbing apolipoprotein E (apoE) on their surface, have previously been considered to deliver various drugs to the brain.	Enbucrilate	46-50	apolipoprotein E	Homo sapiens	92-108	
16036306-2	2005	Polysorbate 80-coated polybutylcyanoacrylate (PBCA) nanoparticles, preferentially adsorbing apolipoprotein E (apoE) on their surface, have previously been considered to deliver various drugs to the brain.	Enbucrilate	46-50	apolipoprotein E	Homo sapiens	110-114